![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 9524 | Ordered by Person (ascending)
1 2 3 ... 27 28 29 ... 94 95 96 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Goldschmidt, Colin (Sonic Healthcare 201701 CEO + Managing Director) | Chief Executive Officer (CEO) | Sonic Healthcare (Group) | Australia |
| Goldsmith, George (Compass Pathways 202004 CEO + Co-Founder) | Chief Executive Officer (CEO) | Compass Pathways (Group) | United Kingdom (GB) |
| Goldsmith, Neil (Sundew 202009 Chairman before Evolva –200910–201707 CEO STEPPED DOWN 7/17) | Chief Executive Officer (CEO) | Sundew ApS | Denmark |
| Goletz, Steffen (Glycotope 201601– CSO before since 200809 Managing Director + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Glycotope (Group) | Germany |
| Goll, Alexandra (TVM 200512) | General Partner (venture partner) | TVM (Group) | Germany |
| Golla, Stephan (Univ of Western Sydney 201203) | n. a. | University of Western Sydney (UWS) | Australia |
| Goller, Alexandra (MorphoSys 201803 Associate Director Corp Comm & IR) | Public Relations Manager / Investor Relations Manager | Novartis (Group) | Germany |
| Golson, Russell (PreOmics 201712– CCO before Computomics + Biognosys + BioSilta + Febit + MWG Biotech) | Chief Commercial Officer (CCO) | Bruker (Group) | Germany |
| Golumbeski, George (Celgene 201804 EVP + Executive Advisor for Innovation + proposed to MorphoSys Supervisory Board) | President/Director/Head Business Group/Unit/Division | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
| Gombert, Till (Protectimmun 200808 Founder) | Company Founder | Protectimmun GmbH | Germany |
| Gonçalves, Dulce (Auven Therapeutics 201409– Corporate Counsel at ADC Therapeutics before Novartis) | General Counsel / Chief Legal Officer (CLO) | ADC Therapeutics (Group) | Switzerland |
| Gonciarz, Grzegorz (Resistell 202007 COO) | Chief Operating Officer (COO) | Resistell AG | Switzerland |
| Gonin, Marc (TOFwerk 202205 CEO + Co-Founder) | Chief Financial Officer (CFO) | TOFwerk AG | Switzerland |
| Gonthiez, Thierry (Resolution Spectra Systems 202007 General Manager + Co-Founder) | General Manager (management) | Merck (DE) (Group) | France |
| González, Juan-José (PolyPeptide 202304– CEO before Ambu A/S + JnJ + Pfizer + McKinsey + Procter & Gamble) | Chief Executive Officer (CEO) | PolyPeptide (Group) | Switzerland |
| Gonzalez-Cadenas, Carlos (Index Ventures 202411 Partner) | Partner (venture partner) | Index Ventures | United Kingdom (GB) |
| Gooch, Daniel (Scius Communciations 202109 formerly Instinctif Partners 201509) | Public Relations Manager / Investor Relations Manager | Scius Communications (GB) | United Kingdom (GB) |
| Goodwin, Elizabeth (Galapagos 201112 Director Investor Relations) | Public Relations Manager / Investor Relations Manager | Galapagos (Group) | Belgium |
| Goorden, Bram (Sophia Genetics 202011– CCO + Head North America before Foundation Medicine + Prometheus Labs + Lilly) | Chief Commercial Officer (CCO) | Sophia Genetics (Group) | United States (USA) |
| Gorbachev, Maxim (Russia (govt) 201501 Partner at RMI Partners) | Partner (venture partner) | Russia (govt) | Russian Federation |
| Gordon, Carl L. (OrbiMed Advisors 201509 Partner) | Partner (venture partner) | OrbiMed (Group) | United States (USA) |
| Gordon, Dale (Mirus Bio 202405 CEO) | Chief Executive Officer (CEO) | Roche (Group) | United States (USA) |
| Gordon, Jenn (Global Health PR 201901) | Public Relations Manager / Investor Relations Manager | Global Health PR (US) | United States (USA) |
| Gordon, Steven J. (Intelligent Bio-Systems 201206 CEO + founder) | Chief Executive Officer (CEO) | Qiagen (Group) | United States (USA) |
| Goris, Ludwig (Capricorn Venture Partners 201808 Investment Manager) | Investment Manager | Capricorn Venture Partners (Group) | Belgium |
| Gorldt, Christian (Transferzentrum für Künstliche Intelligenz-BREMEN.AI 202412 Head) | Cluster Manager | Transferzentrum für Künstliche Intelligenz – BREMEN.AI | Germany |
| Gorman, Kevin (Neurocrine Biosciences 202005 CEO) | Chief Executive Officer (CEO) | Neurocrine Biosciences (Group) | United States (USA) |
| Gorzka, Gabriele (Univ Kassel 201108 Head of OWWZ) | President/Director/Head Business Group/Unit/Division | University of Kassel | Germany |
| Goschin, Jörg (Alstin GmbH 201108– Managing Director before Blackstone Group London + Cerberus Capital) | Managing Director | MASCHMEYER Group (family Maschmeyer) | Germany |
| Gossé, Jörn (Körber 202407 CEO of Körber Pharma before 201905 CEO of Körber Medipak Systems) | Chief Executive Officer (CEO) | Körber (Group) | Germany |
| Gotteland, Jean-Pierre (ObsEva 201701 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ObsEva (Group) | Switzerland |
| Gottraux, Jean-Claude (Roche 201404 Head of Roche Professional Diagnostics) | President/Director/Head Business Group/Unit/Division | Roche (Group) | Switzerland |
| Gottschalk, Gerhard | n. a. | Project »Genomforschung an Mikroorganismen zur Analyse und Nutzung der Biodiversität« (Kompetenznetz, Uni Göttingen) | Germany |
| Gottschalk, Uwe (Keensight Capital 202201– Operating Partner before Lonza + Sartorius + Bayer) | Partner (venture partner) | Keensight Capital SAS | France |
| Gouliaev, Alex Haahr (Nuevolution 201205 CEO + Co-founder before NeuroSearch) | Chief Executive Officer (CEO) | Nuevolution (Group) | Denmark |
| Goundis, Dimitri (MaxiVax 201602– CEO before Acrongenomics + Speedel + Medicines Co Inc + Roche) | Chief Executive Officer (CEO) | MaxiVax S.A. | Switzerland |
| Goutopoulos, Andreas (Merck (DE) 202004 Senior Scientific Director at EMD Serono + CSO at Metabomed + EiR at M Ventures) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Merck (DE) (Group) | United States (USA) |
| Graber, Armin (Biocrates 200502 Managing Director) | Managing Director | Biocrates (Group) | Austria |
| Grabert, Sebastian (Euronext 201709 Director Germany Representative before HSCBC + Berenberg) | Sales Manager / Marketing Manager | Euronext (Group) | Netherlands |
| Grabulovski, Dragan (Bellevue 202109– Venture Partner at Pureos Bioventures before Covagen CSO + co-founder) | Partner (venture partner) | Bellevue (Group) | United Kingdom (GB) |
| Gradnik, Roberto (Merck Serono –200708– Head of Operations Europe) | n. a. | Merck (DE) (Group) | Germany |
| Grady, Patrick (TetraScience 202301 CEO) | Chief Executive Officer (CEO) | TetraScience Inc. | United States (USA) |
| Graewe, Thomas (Amedrix 201109 Managing Director) | Managing Director | Amedrix GmbH | Germany |
| Graf von Stosch, Andreas (Bosch Graf von Stosch Jehle 200809) | n. a. | Bosch Graf von Stosch Jehle (Munich) | Germany |
| Graf, Marcus (Geneart 199911– co-founder + 5/06 head Bus Unit gene synthesis) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | Germany |
| Graf, Peter (Bavaria (govt) 201902 Investment Manager at BayBG) | Investment Manager | Bavaria (govt region) | Germany |
| Graf-Tschupp, Nathalie (Alentis Therapeutics 202111 Officer Manager) | n. a. | Alentis Therapeutics AG | Switzerland |
| Graham, John (Menarini 201504 Chief Executive of Menarini Asia-Pacific Pte Ltd) | Chief Executive Officer (CEO) | Menarini (Group) | Singapore |
| Graham, Peter (ADC Therapeutics 202211– Chief Legal Officer before Halozyme Therapeutics + Delcath Systems) | General Counsel / Chief Legal Officer (CLO) | ADC Therapeutics (Group) | Switzerland |
| Graham, Teresa (Roche 202307 CEO of Roche Pharma) | Chief Executive Officer (CEO) | Roche (Group) | Switzerland |
| Graimann, Bernhard (Otto Bock 201009) | n. a. | Ottobock (Otto Bock) (Group) | Germany |
| Grainger, David (Medixci Ventures 201602– General Partner before Index Ventures 2012– + Funxional Therapeutics) | General Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | United Kingdom (GB) |
| Gramatica, Ruggero (Therametrics –201309 CEO RESIGNED 9/13) | Chief Executive Officer (CEO) | Relief Therapeutics (Group) | Switzerland |
| Grandidier, Laurent (Xeltis 201412 CEO) | Chief Executive Officer (CEO) | Xeltis (Group) | Switzerland |
| Grandison (Schüller), Annika (EMBL 202312 Deputy Head of Communications + Engagement Team Lead) | Public Relations Manager / Investor Relations Manager | EMBL (European Molecular Biology Laboratory) | Germany |
| Grandits, Simona (Qiagen 202401 Senior Director, Head of Sales + Marketing EEMEA) | Sales Manager / Marketing Manager | Qiagen (Group) | Germany |
| Granese, Don (Sophia Genetics 202002 Media Relations Manager US) | Public Relations Manager / Investor Relations Manager | Sophia Genetics (Group) | United States (USA) |
| Graney, Tom (Oxurion 202105– CEO joined as CFO 10/20 before Generation Bio + Vertex Pharma + Ironwood Pharma + JnJ) | Chief Executive Officer (CEO) | Oxurion (Group) | Belgium |
| Granger, Chris (Immunotec 200508 Director of Sales) | Sales Manager / Marketing Manager | IMMUNOTEC Immunologisch-technische Produkt- und Beratungs GmbH | Germany |
| Granier, Benoit (Unisensor (BE) 201805 CEO) | Chief Executive Officer (CEO) | Unisensor S.A. (BE) | Belgium |
| Grant, Nick (AMETEK 201610 VP Material Analysis Division) | President/Director/Head Business Group/Unit/Division | AMETEK (Group) | United States (USA) |
| Granzer, Ulrich | Venture Partner | Wellington Partners (Group) | Germany |
| Gras, Guillaume (ECBF 202309 Investment Director) | Investment Manager | ECBF (European Circular Bioeconomy Fund) (Group) | Germany |
| Gras, Jan Christoph (Planet A 202302 Partner) | Partner (venture partner) | Planet A GmbH (Planet A Ventures) | Germany |
| Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO) | Chief Executive Officer (CEO) | Marinomed Biotech AG (VSE: MARI) | Austria |
| Grassmann, Heike (Helmholtz 202210 Administrative Director at Max Delbrück Center) | President/Director/Head of Research Organisation/Unit | Helmholtz-Gemeinschaft (HGF) (Group) | Germany |
| Grau, Daniel (Avilar Therapeutics 202111 CEO formerly Heptares + Cortia Corp + CombinatoRx) | Chief Executive Officer (CEO) | Avilar Therapeutics Inc. | United States (USA) |
| Grau, Michael (Kuros 202209 CFO before Proteros + Correvio + Ingenium + MorphoSys) | Chief Financial Officer (CFO) | Kuros (Group) | Switzerland |
| Grau, Ulrich (Micromet 201106–2012 COO before Lux Biosciences CEO before Enzon 2002–2005 CSO before BASF/Knoll) | Chief Operating Officer (COO) | Amgen (Group) | Germany |
| Grau, Volker (SMS Service für Massenspektrometrie GmbH 2008 Managing Director) | Managing Director | SMS Service für Massenspektrometrie GmbH | Germany |
| Graupner, Stefan | n. a. | University of Bremen | Germany |
| Graves, Jeffrey (3D Systems 202202 CEO) | n. a. | 3D Systems (Group) | United States (USA) |
| Grawunder, Ulf (T-Curx 202210– CEO + Co-Founder before NBE Therapeutics + 4-Antibody) | Chief Executive Officer (CEO) | T-Curx GmbH | Germany |
| Gray, Michael (Mike) (Arsanis 201702 CFO + CBO) | Chief Financial Officer (CFO) | Arsanis (Group) | United States (USA) |
| Graziano, John (Trout Group 201609) | Public Relations Manager / Investor Relations Manager | PNC Financial Services (Group) | United States (USA) |
| Gre(h)ling, Frau (Heidelberg Innovation 200504) | n. a. | Heidelberg Innovation (Group) | Germany |
| Green, Eric (Sigma-Aldrich 200604) | n. a. | Merck (DE) (Group) | United States (USA) |
| Green, Nicholas (Coulter Partners 202406– promoted to CEO from Managing Partner joined CP in start-up phase) | Managing Partner | Coulter Partners (The Coulter Partnership Ltd.) | United Kingdom (GB) |
| Green, Nicola (Halesway Ltd 201201– Account Director before Alto Marketing 201110 Account Director, Life Science) | public relations / investor relations | Halesway Ltd. | United Kingdom (GB) |
| Greene, James (MedLumics 202102 CEO) | Chief Executive Officer (CEO) | MedLumics S.L. | Spain (España) |
| Greenstreet, Yvonne (Alnylam 202307 CEO formerly GSK 200708 Senior VP Medicine Develp Centre) | Chief Executive Officer (CEO) | Alnylam (Group) | United States (USA) |
| Greenwood, James (Jim) (Biotechnology Industry Organization 201407 President + CEO) | Chief Executive Officer (CEO) | BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) | United States (USA) |
| Grego, Jaime (Laboratorios LETI 201401 President) | President/Director/Head Business Group/Unit/Division | Laboratorios LETI (Group) | Spain (España) |
| Grégoire, Sylvie (Shire President Human Genetic Therapies before IDM Pharma + GlycoFi + Biogen + Merck & Co) | n. a. | Takeda (Group) | Ireland, Republic of |
| Gregory, Philip (Bluebird Bio 201805 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bluebird Bio (Group) | United States (USA) |
| Greiner, Axel (Greiner 200804 CEO) | Chief Executive Officer (CEO) | Greiner (Group) | Austria |
| Greiner, Boris (Greiner 200804 CEO) | Chief Executive Officer (CEO) | Greiner (Group) | Austria |
| Greiner, Erich F. (Cedrus Therapeutics 201704 before Evotec 200604) | n. a. | Cedrus Therapeutics (Group) | Germany |
| Greiner, Peter (Greiner 200809 Managing Director) | Managing Director | Greiner (Group) | Austria |
| Greshake, Dirk (AstraZeneca 201305– Managing Director at AstraZeneca GmbH) | Managing Director | AstraZeneca (Group) | Germany |
| Greubel, Rick (Kaiima 201707 CEO) | Chief Executive Officer (CEO) | Kaiima Bio-Agritech Ltd. | Israel |
| Greuel, Joachim M. (Bioscience Valuation BSV GmbH 20203 Managing Director) | Managing Director | Bioscience Valuation BSV GmbH | Germany |
| Greve, Michael (Forevery Healthy 202209 Manaing Director + Kizoo Founder/Owner) | Chief Operating Officer (COO) | Forever Healthy (Kizoo / Michael Greve) (Group) | Germany |
| Greving, Matthew (Nextval 201210 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Nextval Inc. | United States (USA) |
| Grewar, Jane (Limerston Capital 202501 Senior Operating Partner + Cormica 202501 Board Chair) | Partner (venture partner) | Limerston Capital LLP (Limerston Capital Partners) | United Kingdom (GB) |
| Grewing, Thomas (Anchor Diagnostics 201508 Qiagen 200603 Director RnD Assay Development) | Managing Director | Anchor Diagnostics GmbH | Germany |
| Gribbon, Philip (European ScreeningPort 200810 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Fraunhofer (Group) | Germany |
| Griebel, Ralf (Tecan 202102 Head Partnering Business) | Business Development Manager / Strategy Manager | Tecan (Group) | Switzerland |
| Griesbeck, Oliver (Max Planck Institute for Biochemistry 200808) | n. a. | Max Planck Society for the Advancement of Science | Germany |
| Griesinger, Christian (Max Planck 1999– Director + Scientific Member MPIBPC Göttingen before Univ Frankfurt Professor) | Professor | University of Frankfurt (Goethe-Universität) |
1 2 3 ... 27 28 29 ... 94 95 96
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
